Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Sales | 369,585 | 326,187 | 319,722 | 309,127 | 263,517 |
| Cost of Goods | 48,704 | 40,842 | 42,092 | 34,949 | 33,277 |
| Gross Profit | 320,881 | 285,345 | 277,630 | 274,178 | 230,240 |
| Operating Expenses | 160,589 | 122,417 | 119,524 | 130,704 | 142,540 |
| Operating Income | 160,996 | 163,770 | 158,198 | 144,423 | 87,977 |
| Interest Expense | 1,143 | 2,042 | 2,071 | 2,089 | 5,176 |
| Other Income | 2,667 | 4,801 | 5,408 | 23,504 | 2,462 |
| Pre-tax Income | 162,520 | 166,529 | 161,535 | 165,838 | 85,263 |
| Income Tax | 52,276 | 53,289 | 50,076 | 51,410 | -107,320 |
| Net Income Continuous | 110,244 | 113,240 | 111,459 | 114,428 | 192,583 |
| Net Income | $110,244 | $113,240 | $111,459 | $114,428 | $192,583 |
| EPS Basic Total Ops | 0.06 | 0.07 | 0.07 | 0.07 | 0.12 |
| EPS Basic Continuous Ops | 0.06 | 0.07 | 0.06 | 0.07 | 0.12 |
| EPS Diluted Total Ops | 0.06 | 0.06 | 0.06 | 0.06 | 0.13 |
| EPS Diluted Continuous Ops | 0.06 | 0.06 | 0.06 | 0.06 | 0.14 |
| EBITDA(a) | $167,425 | $169,888 | $164,209 | $150,273 | $94,134 |